Obesity Pharmacotherapy: An Urgent Need for Progressing Science, Access, and Equity

In October 2024, multi-industry stakeholders gathered for the DCRI Think Tank Anti-Obesity Pharmacotherapy: Need for Guidance, Access, and Equity, which focused on aligning and advancing the field of obesity medications (OMs). Their insights and collaboration resulted in the article Obesity…